Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIT Mixture (Grass + Mite) vs Monotherapy in Allergy
NCT04874714Phase 3Terminated
- Sponsor
- Inmunotek
- Start
- Apr 2021
- Primary completion
- Oct 2023
- Modality
- Split/Subunit Vaccines, Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of Clustoid MM09, MG01 in allergic rhinoconjunctivitis (ARC), asthma, sponsored by Inmunotek. Started Apr 2021; status: terminated.
02
Drugs
Clustoid MM09MG01
03
Conditions
allergic rhinoconjunctivitis (ARC)asthma
Beyond the preview
Go deeper on NCT04874714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874714.